Cradle

Cradle is building a platform that leverages AI to accelerate protein engineering and discovery for biopharma and industrial bio R&D teams. Their platform aims to reduce development time and improve the properties of protein candidates, leading to more breakthroughs with fewer experiments. This is achieved by generating protein candidates, tracking the experimental process, and managing data effectively, enabling a more efficient and data-driven approach to biological innovation. Cradle's core value proposition is to make biology programmable, allowing scientists to decode and rewrite biological systems to unlock new food sources, materials, and therapeutics. The company focuses on partnering with top biopharma companies and industrial bio R&D teams, embedding advanced AI directly into their innovation processes. By doing so, Cradle enables these teams to shorten development time and bring real-world biosolutions faster to market. Cradle’s platform facilitates the generation of candidates, data management, and report exploration, effectively serving as a comprehensive AI-powered tool for protein engineering. Cradle is addressing the critical need for faster and more efficient protein engineering by creating an integrated solution that encompasses candidate generation, experimental data management, and reporting. This approach streamlines the traditionally complex and lengthy process of protein design and optimization, allowing their customers to achieve significant improvements in development time and efficacy. The company's platform is validated through customer testimonials and case studies, demonstrating tangible benefits such as enhanced binding affinity and faster enzyme design.

AI-powered protein engineering, drug discovery, biotechnology, biosolutions, biopharma, industrial bio

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.